These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 39028290)
1. Consensus clustering and novel risk score model construction based on m6A methylation regulators to evaluate the prognosis and tumor immune microenvironment of early-stage lung adenocarcinoma. He M; Zhi Y; Li C; Zhao C; Yang G; Lv J; You H; Huang H; Cao X Aging (Albany NY); 2024 Jul; 16(14):11318-11338. PubMed ID: 39028290 [TBL] [Abstract][Full Text] [Related]
2. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment. Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861 [TBL] [Abstract][Full Text] [Related]
3. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma. Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment. Yu L; Cao S; Li J; Han B; Zhong H; Zhong R Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738 [TBL] [Abstract][Full Text] [Related]
6. [Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma]. Ke J; Cui J; Yang X; Du X; Ma B; Yu L Zhongguo Fei Ai Za Zhi; 2022 May; 25(5):311-322. PubMed ID: 35599007 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Wang W; Ren S; Wang Z; Zhang C; Huang J Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070 [TBL] [Abstract][Full Text] [Related]
8. Deciphering N Zhu J; Wang M; Hu D Biomed Res Int; 2020; 2020():2514230. PubMed ID: 32258108 [TBL] [Abstract][Full Text] [Related]
9. The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration. Wu X; Wu Z; Xie Z; Huang H; Wang Y; Lv K; Yang H; Liu X Int Immunopharmacol; 2024 Sep; 138():112553. PubMed ID: 38943975 [TBL] [Abstract][Full Text] [Related]
10. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A. Zhao W; Xie Y Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400 [TBL] [Abstract][Full Text] [Related]
11. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis. Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ Front Immunol; 2021; 12():724741. PubMed ID: 34335635 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma. Tian L; Wang Y; Tian J; Song W; Li L; Che G Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047493 [TBL] [Abstract][Full Text] [Related]
13. Identifying an immunogenic cell death-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma. Li X; Zhang D; Guo P; Ma S; Gao S; Li S; Yuan Y Aging (Albany NY); 2024 Apr; 16(7):6290-6313. PubMed ID: 38575204 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUAD. Chen JL; Wu CY; Luo XY; Wang XY; Wang FM; Huang X; Yuan W; Guo Q Sci Rep; 2024 May; 14(1):11782. PubMed ID: 38782996 [TBL] [Abstract][Full Text] [Related]
15. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor. Yu L; Qiao R; Xu J; Han B; Zhong R Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533 [TBL] [Abstract][Full Text] [Related]
16. Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma. Wang N; Xu Y; Jin L; Wang X; Wu S; Wang Y; Zhao J; Zhou F; Ge H Dis Markers; 2022; 2022():1829528. PubMed ID: 36051357 [TBL] [Abstract][Full Text] [Related]
17. SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression. Quan S; Li N; Lian S; Wang Y; Liu Y; Liu J; Zhang Z; Gao D; Li Y Int Immunopharmacol; 2024 Oct; 140():112756. PubMed ID: 39083932 [TBL] [Abstract][Full Text] [Related]
18. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma. Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis for Predicting Prognoses and Immune Responses of m6A-Related lncRNAs in Women with Lung Adenocarcinoma. Wu S; Tu Q; Yuan H; Wu Z; Yang Y; Chen C; Huang C Biochem Genet; 2024 Aug; 62(4):2702-2720. PubMed ID: 37999876 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Cell Death Index for Lung Adenocarcinoma: A Comprehensive Transcriptome-Based Analysis of Twelve Programmed Cell Death Pattern Genes. Chen F; Ma J; Hu S; Wu C; Chen S; Lin J Front Biosci (Landmark Ed); 2024 Apr; 29(4):135. PubMed ID: 38682187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]